Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e773-e776. doi: 10.1111/jdv.16863. Epub 2020 Sep 17.

Authors

N D Loft^{1

2}, A-S Halling^{1

2}, L Iversen³, C Vestergaard³, M Deleuran³, M K Rasmussen³, C Zachariae^{1

2}, J P Thyssen^{1

2}, L Skov^{1

2}

Affiliations

¹ Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
² Copenhagen Research Group for Inflammatory Skin (CORGIS), Herlev and Gentofte Hospital, Hellerup, Denmark.
³ Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
COVID-19*
Denmark
Dermatitis, Atopic / therapy*
Fear
Female
Humans
Immunomodulation*
Male
Middle Aged
Patient Compliance / psychology*
Psoriasis / therapy*
Young Adult